We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.87%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAVE
976
DELISTED
Spirit Airlines, Inc.
SAVE
$1.58M ﹤0.01%
432,494
+332,188
+331% +$1.29M
LNT icon
977
Alliant Energy
LNT
$17.1B
$1.56M ﹤0.01%
30,680
-573
-2% -$28.8K
RRR icon
978
Red Rock Resorts
RRR
$3.15B
$1.56M ﹤0.01%
28,330
THR
979
DELISTED
Thermon Group Holdings
THR
$1.55M ﹤0.01%
50,372
-151,740
-75% -$4.86M
FLS icon
980
Flowserve
FLS
$9.19B
$1.54M ﹤0.01%
32,008
-592
-2% -$28.3K
DCH
981
Dauch Corp
DCH
$1.43B
$1.53M ﹤0.01%
219,509
+100,231
+84% +$739K
CW icon
982
Curtiss-Wright
CW
$21.1B
$1.53M ﹤0.01%
5,659
+1,544
+38% +$413K
OGN icon
983
Organon & Co
OGN
$3.59B
$1.53M ﹤0.01%
74,013
+74,008
+1,480,160% +$1.47M
EPAC icon
984
Enerpac Tool Group
EPAC
$1.83B
$1.53M ﹤0.01%
40,006
-36,429
-48% -$1.35M
ZYME icon
985
Zymeworks
ZYME
$1.88B
$1.53M ﹤0.01%
179,381
-1,166
-0.6% -$10.4K
PFG icon
986
Principal Financial Group
PFG
$25B
$1.52M ﹤0.01%
19,430
+1,370
+8% +$111K
COLB icon
987
Columbia Banking Systems
COLB
$8.41B
$1.52M ﹤0.01%
76,467
-89,596
-54% -$1.7M
TILE icon
988
Interface
TILE
$2B
$1.51M ﹤0.01%
103,197
+39
+0% +$606
ERIC icon
989
Ericsson
ERIC
$32.7B
$1.49M ﹤0.01%
242,082
-493,416
-67% -$2.76M
LZ icon
990
LegalZoom.com
LZ
$1.04B
$1.47M ﹤0.01%
175,298
-48,815
-22% -$503K
TPL icon
991
Texas Pacific Land
TPL
$24B
$1.47M ﹤0.01%
+5,988
New +$1.26M
KEYS icon
992
Keysight
KEYS
$54.8B
$1.45M ﹤0.01%
10,623
-674
-6% -$98.5K
EMR icon
993
Emerson Electric
EMR
$81.3B
$1.45M ﹤0.01%
13,171
-359
-3% -$39.7K
LEA icon
994
Lear
LEA
$6.08B
$1.45M ﹤0.01%
12,670
-11
-0.1% -$1.41K
DLTR icon
995
Dollar Tree
DLTR
$21.1B
$1.43M ﹤0.01%
13,367
+209
+2% +$24.7K
WSO icon
996
Watsco Inc
WSO
$12.5B
$1.43M ﹤0.01%
3,079
-13
-0.4% -$5.94K
RBBN icon
997
Ribbon Communications
RBBN
$293M
$1.42M ﹤0.01%
432,205
SJM icon
998
J.M. Smucker
SJM
$13.2B
$1.42M ﹤0.01%
12,989
-1,646
-11% -$186K
CYTK icon
999
Cytokinetics
CYTK
$9.65B
$1.41M ﹤0.01%
26,098
+17,530
+205% +$1.06M
WPC icon
1000
W.P. Carey
WPC
$15.2B
$1.41M ﹤0.01%
25,543
+3,987
+18% +$225K

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.